TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35361325

Group type: EXPERIMENTAL
Intervention: 5% urea containing hydrophilic petrolatum
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 10% urea containing hydrophilic petrolatum
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Commercial products
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Commercial emollient
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Commercial formulation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cream-based formulation
Number of subjects: 30

Group type: COMPARATOR
Intervention: No treatment area
Number of subjects: 30
Study: 36240972

Group type: EXPERIMENTAL
Intervention: Durvalumab plus Tremelimumab
Number of subjects: 823

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 823
Study: 35753770

Group type: EXPERIMENTAL
Intervention: Sotrovimab
Number of subjects: 60
Study: 35118971

Group type: EXPERIMENTAL
Intervention: Tablet-based interactive distraction
Number of subjects: 70
Study: 33614699

Group type: EXPERIMENTAL
Intervention: Suprasorb CNP
Number of subjects: 34

Group type: COMPARATOR
Intervention: AB‐Thera
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both systems
Number of subjects: 34
Study: 35686900

Group type: EXPERIMENTAL
Intervention: Topical 5% permethrin and oral placebo (Group A)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Topical placebo cream and oral ivermectin (Group B)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Topical 1% gamma benzene hexachloride and oral placebo (Group C)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Topical 5% permethrin and oral ivermectin (Group D)
Number of subjects: 120
Study: 33357109

Group type: EXPERIMENTAL
Intervention: Posterior fossa decompression (PFD) and superficial durotomy surgery (Group 2)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Classic PFD and duraplasty (Group 1)
Number of subjects: 54
Study: 32392715

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Treatment (ILT) - diet plus exercise with monthly visits
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard Care (Control)
Number of subjects: 76
Study: 33887952

Group type: EXPERIMENTAL
Intervention: Bridge peer health navigator intervention
Number of subjects: 144
Study: 33470646

Group type: EXPERIMENTAL
Intervention: Tonometric blood pressure monitor (Bpro; HealthSTATS International, Singapore)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Oscillometric cuff-based device (Oscar 2; Sun Tech Medical)
Number of subjects: 33
Study: 35689818

Group type: EXPERIMENTAL
Intervention: Oral sulfate tablets (OST)
Number of subjects: 110

Group type: COMPARATOR
Intervention: 2 L polyethylene glycol and ascorbate (PEG/Asc)
Number of subjects: 110
Study: 33011852

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS)
Number of subjects: 3
Study: 33817938

Group type: EXPERIMENTAL
Intervention: HIV patients
Number of subjects: 379

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: CVR equations
Number of subjects: 379
Study: 32367437

Group type: EXPERIMENTAL
Intervention: Interferon-beta plus temozolomide (TMZ)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Temozolomide (TMZ) alone
Number of subjects: 122
Study: 32780234

Group type: EXPERIMENTAL
Intervention: Flexible endoscopic myotomy (window technique)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Open cervicotomy
Number of subjects: 106

Group type: COMPARATOR
Intervention: Rigid endoscopy
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Flexible endoscopy
Number of subjects: 106

Group type: COMPARATOR
Intervention: Cervicotomy
Number of subjects: 106
Study: 33180253

Group type: EXPERIMENTAL
Intervention: Maisha intervention
Number of subjects: 1039

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 1039
Study: 32818553

Group type: EXPERIMENTAL
Intervention: BCNU/TT based conditioning regimen
Number of subjects: 56

Group type: COMPARATOR
Intervention: BEAM (non-thiotepa) based conditioning regimen
Number of subjects: 56
Study: 35098682

Group type: EXPERIMENTAL
Intervention: Radiomics score (rad-score) for patients with EGFR mutations
Number of subjects: 1092

Group type: COMPARATOR
Intervention: Radiomics score (rad-score) for patients with EGFR wild-type
Number of subjects: 1092

Group type: EXPERIMENTAL
Intervention: Nomogram combining radiomics and clinical features
Number of subjects: 1092
Study: 32737604

Group type: EXPERIMENTAL
Intervention: Dose-Response Mixed Models for Repeated Measures (DR-MMRM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional Mixed Models for Repeated Measures (MMRM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dose-response model
Number of subjects: 0
Study: 33880653

Group type: EXPERIMENTAL
Intervention: Reversed total shoulder prosthetic replacement (RTSA)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Open reduction and internal fixation (ORIF) using a proximal humerus locking plate (PHILOS)
Number of subjects: 54
Study: 33076902

Group type: EXPERIMENTAL
Intervention: Estrogen treatment
Number of subjects: 76

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 76
Study: 36061219

Group type: EXPERIMENTAL
Intervention: Food Choice Questionnaire (FCQ)
Number of subjects: 385
Study: 32195215

Group type: EXPERIMENTAL
Intervention: Behavior change group (n = 36)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Traditional exercise group (n = 52)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group (n = 26)
Number of subjects: 114
Study: 33837086

Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard American (SA) diet
Number of subjects: 33
Study: 35021015

Group type: EXPERIMENTAL
Intervention: Linguistic-phonological intervention to eliminate anterior oral CSCs
Number of subjects: 14

Group type: COMPARATOR
Intervention: Motor-phonetic intervention to eliminate anterior oral CSCs
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Motor-phonetic intervention to eliminate non-oral CSCs
Number of subjects: 14

Group type: COMPARATOR
Intervention: Linguistic-phonological intervention to eliminate non-oral CSCs
Number of subjects: 14
Study: 33648474

Group type: EXPERIMENTAL
Intervention: Goal-directed therapeutic exercise program (12 weeks, face-to-face, with home-based program 3 sessions per week)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Goal-directed therapeutic exercise program
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 48
Study: 36294321

Group type: EXPERIMENTAL
Intervention: VL-emitting eyeglass frames (VLf) that emitted VL of 310 μW/cm2 (n = 22)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Pseudo-placebo eyeglass frames with a minimal emission of VL (<10 μW/cm2) (control group, n = 21)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: VL-emitting eyeglass frames (VLf)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Pseudo-placebo eyeglass frames (control group)
Number of subjects: 43
Study: 34678709

Group type: EXPERIMENTAL
Intervention: Nine-session anxiety prevention program
Number of subjects: 86

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 86
Study: 33609135

Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 33°C for 24 hours (TTM24)
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 33°C for 48 hours (TTM48)
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: From 24 to 48 hours in TTM48 group
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: High vasopressor load
Number of subjects: 311
Study: 34184976

Group type: EXPERIMENTAL
Intervention: Concussion Coach
Number of subjects: 461

Group type: COMPARATOR
Intervention: Treatment-as-Usual (TAU)
Number of subjects: 461
Study: 32757569

Group type: EXPERIMENTAL
Intervention: Training condition where children were taught about sarcasm and cues to look for during interactions with the researcher.
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control condition where children read a nonsarcastic storybook with the researcher.
Number of subjects: 111
Study: 32381840

Group type: EXPERIMENTAL
Intervention: SRP plus Periochip™
Number of subjects: 20

Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 20
Study: 36368761

Group type: EXPERIMENTAL
Intervention: Immediate mobilisation
Number of subjects: 240

Group type: COMPARATOR
Intervention: Postoperative 2-week casting
Number of subjects: 240
Study: 33125272

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle plus abdominal training (PFMT+AT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 64
Study: 32517192

Group type: EXPERIMENTAL
Intervention: Oral magnesium supplementation (400 mg magnesium/day in the form of magnesium oxide)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 35001651

Group type: EXPERIMENTAL
Intervention: carboxytherapy and vibratory device A
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: carboxytherapy and vibratory device B
Number of subjects: 78

Group type: COMPARATOR
Intervention: control group
Number of subjects: 78
Study: 33184437

Group type: EXPERIMENTAL
Intervention: Dietary probiotic supplement of four viable strains of Lactobacillus twice-daily for 14 days
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 35063952

Group type: EXPERIMENTAL
Intervention: MetaWell programme (diet replacement products, wireless scales, mobile phone app)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Paper material containing a sample diet for weight loss
Number of subjects: 220
Study: 33037656

Group type: EXPERIMENTAL
Intervention: recombinant human GH (rhGH)
Number of subjects: 24

Group type: COMPARATOR
Intervention: no treatment
Number of subjects: 24
Study: 35407595

Group type: EXPERIMENTAL
Intervention: Negative pulsed-pressure myofascial vacuum therapy (VT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Physical therapy program (PTP) based only on core therapeutic exercise
Number of subjects: 50
Study: 32763548

Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Quetiapine (100 mg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Olanzapine (10 mg)
Number of subjects: 45
Study: 34150674

Group type: EXPERIMENTAL
Intervention: Oral liposomal glutathione supplementation (L-GSH) for 3 months
Number of subjects: 0
Study: 32433194

Group type: EXPERIMENTAL
Intervention: C-arm
Number of subjects: 12

Group type: COMPARATOR
Intervention: O-arm
Number of subjects: 12
Study: 36325677

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) once a week for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 60
Study: 34446114

Group type: EXPERIMENTAL
Intervention: Bouldering psychotherapy (BPT)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Home-based physical exercise program (EP)
Number of subjects: 233
Study: 33211710

Group type: EXPERIMENTAL
Intervention: Integration of TB screening into IMNCI clinics during intervention period
Number of subjects: 180896

Group type: EXPERIMENTAL
Intervention: Contact investigation in TB clinics during intervention period
Number of subjects: 180896

Group type: EXPERIMENTAL
Intervention: Overall integration of TB screening and contact investigation
Number of subjects: 180896
Study: 35833298

Group type: EXPERIMENTAL
Intervention: 7+3 induction chemotherapy
Number of subjects: 1247
Study: 34526067

Group type: EXPERIMENTAL
Intervention: Ravulizumab
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Ravulizumab and Eculizumab
Number of subjects: 438
Study: 34228086

Group type: EXPERIMENTAL
Intervention: Antibiotic initiation letter (n = 1500)
Number of subjects: 3465

Group type: EXPERIMENTAL
Intervention: Antibiotic duration letter (n = 1500)
Number of subjects: 3465

Group type: COMPARATOR
Intervention: Control group (no letter; n = 500)
Number of subjects: 3465
Study: 32033576

Group type: EXPERIMENTAL
Intervention: Checklist-based box system interventions
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Routine standard of care
Number of subjects: 1200
Study: 35820743

Group type: EXPERIMENTAL
Intervention: 4 mg guanabenz acetate
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 8 mg guanabenz acetate
Number of subjects: 28
Study: 32755065

Group type: EXPERIMENTAL
Intervention: Direct perineal wound full-thick closure (DPWC)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Incisional negative pressure wound therapy (NPA group)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Hypoalbuminemia
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional perineal wound closure (CPWC)
Number of subjects: 44
Study: 35325597

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35762390

Group type: EXPERIMENTAL
Intervention: IDegLira
Number of subjects: 720

Group type: COMPARATOR
Intervention: Degludec
Number of subjects: 720

Group type: COMPARATOR
Intervention: Liraglutide
Number of subjects: 720
Study: 33413417

Group type: EXPERIMENTAL
Intervention: Seasonal Malaria Chemoprevention (SMC) for 4 years
Number of subjects: 461

Group type: COMPARATOR
Intervention: Seasonal Malaria Chemoprevention (SMC) for 2 years
Number of subjects: 461
Study: 32375688

Group type: EXPERIMENTAL
Intervention: 2 cycles of neoadjuvant chemotherapy (NAC)
Number of subjects: 298

Group type: COMPARATOR
Intervention: 3 cycles of neoadjuvant chemotherapy (NAC)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Both groups will undergo interval debulking surgery (IDS) and then receive 3 or 4 cycles of adjuvant chemotherapy for a total of 6 cycles.
Number of subjects: 298
Study: 34448876

Group type: EXPERIMENTAL
Intervention: Full-length transcriptome SMRT and Illumina RNA sequencing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gas chromatography-mass spectrometry
Number of subjects: 0
Study: 34885998

Group type: EXPERIMENTAL
Intervention: Intensive structured intervention to improve motor skills
Number of subjects: 471

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 471
Study: 32221043

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 10
Study: 35569564

Group type: EXPERIMENTAL
Intervention: Biomarkers indicating cardiorenal dysfunction and inflammation (NT‐proBNP, troponin T, cystatin C, GDF‐15, IL‐6, CRP) in patients with HFrEF
Number of subjects: 11818

Group type: EXPERIMENTAL
Intervention: Biomarkers indicating cardiorenal dysfunction and inflammation (NT‐proBNP, troponin T, cystatin C, GDF‐15, IL‐6, CRP) in patients with HFpEF
Number of subjects: 11818

Group type: EXPERIMENTAL
Intervention: Biomarkers indicating cardiorenal dysfunction and inflammation (NT‐proBNP, troponin T, cystatin C, GDF‐15, IL‐6, CRP) in patients with No HF
Number of subjects: 11818
Study: 33263788

Group type: EXPERIMENTAL
Intervention: Higher-satiety food (HSF) group
Number of subjects: 82

Group type: COMPARATOR
Intervention: Lower-satiety food (LSF) group
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Very-low-energy diet (VLED)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Weight maintenance (WM) period
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Fasting appetite-related hormones
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Changes in ghrelin levels
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Changes in leptin and insulin levels
Number of subjects: 82
Study: 34913497

Group type: EXPERIMENTAL
Intervention: TMFI + Steroid
Number of subjects: 21

Group type: COMPARATOR
Intervention: Steroid injection
Number of subjects: 21
Study: 33663090

Group type: EXPERIMENTAL
Intervention: Auricular acupoint stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 0
Study: 32762115

Group type: EXPERIMENTAL
Intervention: Irbesartan 100 mg/amlodipine 10 mg (Group 1)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Indapamide 1 mg in addition to ARBs plus amlodipine 5 mg (Group 2)
Number of subjects: 94
Study: 36137765

Group type: EXPERIMENTAL
Intervention: Pre-transfusion haemoglobin <75g/L
Number of subjects: 0
Study: 33350863

Group type: COMPARATOR
Intervention: Lebrikizumab (IL-13 inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tralokinumab (IL-13 monoclonal antibody)
Number of subjects: 0
Study: 32822683

Group type: EXPERIMENTAL
Intervention: Back-and-forth technique
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Concentric circle technique
Number of subjects: 132

Group type: COMPARATOR
Intervention: Comparison of both techniques
Number of subjects: 132
Study: 36124407

Group type: EXPERIMENTAL
Intervention: Anterior leaflet prolapse repair
Number of subjects: 74

Group type: COMPARATOR
Intervention: Posterior leaflet prolapse repair
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Left ventricle end-systolic diameter
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Left ventricle end-systolic diameter ≤42 mm
Number of subjects: 74
Study: 33516644

Group type: EXPERIMENTAL
Intervention: Gemcitabine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Best Supportive Care (BSC)
Number of subjects: 24
Study: 35325728

Group type: EXPERIMENTAL
Intervention: Cerebellar anodal transcranial direct current stimulation (a‐tDCS) concurrent with postural training (cerebellar a‐CSC‐PT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sham tDCSC‐PT
Number of subjects: 37

Group type: COMPARATOR
Intervention: Postural training alone
Number of subjects: 37
Study: 32659768

Group type: EXPERIMENTAL
Intervention: Ostrich oil massage (1 mL on pruritus area for 10 min each night for 1 month)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo massage
Number of subjects: 68
Study: 36454825

Group type: EXPERIMENTAL
Intervention: eOD-GT8 60mer adjuvanted with AS01B
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34227708

Group type: EXPERIMENTAL
Intervention: Tegoprazan 50 mg
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Tegoprazan 100 mg
Number of subjects: 324

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 324
Study: 32217922

Group type: EXPERIMENTAL
Intervention: Preoperative frailty and mobility assessments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 0
Study: 32533763

Group type: EXPERIMENTAL
Intervention: Manual lymphatic drainage (MLD)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Perineal massage
Number of subjects: 49
Study: 36216204

Group type: EXPERIMENTAL
Intervention: Remimazolam (Group R)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Midazolam (Group M)
Number of subjects: 40
Study: 33446158

Group type: EXPERIMENTAL
Intervention: Mobile phone-based text message intervention (45 text messages over 45 days)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Mobile phone-based text message intervention
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 136
Study: 36399476

Group type: EXPERIMENTAL
Intervention: Community-based bilingual doula (CBD) support
Number of subjects: 164

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 164
Study: 35389054

Group type: EXPERIMENTAL
Intervention: Skin-adhesive low-level light therapy (LLLT) device (Color DNA-WSF) applied three times daily for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham device applied three times daily for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Skin-adhesive low-level light therapy (LLLT) device (Color DNA-WSF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both LLLT and sham devices
Number of subjects: 0
Study: 33704913

Group type: EXPERIMENTAL
Intervention: In-bed cycle exercise (20 minutes, 5 days per week for 3 weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 52
Study: 32768993

Group type: EXPERIMENTAL
Intervention: Insomnia Severity Index
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: B-MAST
Number of subjects: 123
Study: 33565051

Group type: EXPERIMENTAL
Intervention: Modified needle (scrubbed with an 11 scalpel blade for 150 seconds)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard needle (control group A)
Number of subjects: 16
Study: 32872022

Group type: EXPERIMENTAL
Intervention: Cryoablation combined with 28-days TCM formula
Number of subjects: 450

Group type: COMPARATOR
Intervention: 4 cycles of chemotherapy
Number of subjects: 450
Study: 36480678

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 68

Group type: COMPARATOR
Intervention: Acupressure Sham
Number of subjects: 68
Study: 33219313

Group type: EXPERIMENTAL
Intervention: 125 mg MDMA
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 32073564

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intranasal Glycyrrhetic acid (GlyAc)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study: 34758065

Group type: EXPERIMENTAL
Intervention: Escitalopram or Duloxetine
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Antidepressant response
Number of subjects: 121
Study: 611925637

Group type: EXPERIMENTAL
Intervention: beta-alanine supplementation (3 g/day for 7 days, then 6 g/day for 23 days)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: beta-alanine supplementation
Number of subjects: 14
Study: 32758017

Group type: EXPERIMENTAL
Intervention: Stent A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stent B
Number of subjects: 0
Study: 33248595

Group type: EXPERIMENTAL
Intervention: Lohmann Brown-classic (LB) hens
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lohmann LSL-classic (LSL) hens
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both strains
Number of subjects: 20
Study: 36169441

Group type: EXPERIMENTAL
Intervention: Beifushu eye drops (recombinant bovine basic fibroblast growth factor) 6 times daily for 1 week
Number of subjects: 118

Group type: COMPARATOR
Intervention: 0.1% sodium hyaluronate eye drops (artificial tears) 6 times daily for 1 week
Number of subjects: 118